Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xiao'er haoqin anti-cold granules
- Development stage
- Phase 2
- Lead developer
- Suzhou Youseen
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xiao'er Haoqin Anti-cold Granules is a traditional Chinese medicine (TCM) candidate developed by Suzhou Yusen New Drug Development Co., Ltd. for the treatment of acute upper respiratory tract infections (URTI) in children. The formulation is specifically designed to address the "wind-heat with dampness" syndrome, a common TCM classification for respiratory ailments characterized by fever, sore throat, and dampness-related symptoms. It is currently undergoing Phase II clinical evaluation in China (Trial ID: CTR20240277) to assess its efficacy and safety in pediatric patients aged 3 to 12 years. As a multi-component herbal granule, it aims to provide a standardized therapeutic option for pediatric URTI within the framework of traditional medicine.
- Other names
- Pediatric Haoqin Anti-cold GranulesXiao'er Haoqin Kanggan Keli
02
Targets
AKT (RAC-alpha serine/threonine-protein kinase)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)
Beyond the preview
Go deeper on xiao'er haoqin anti-cold granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xiao'er haoqin anti-cold granules.